Key information

🔎 Fund Overview

WuXi PharmaTech (Cayman) Inc. operates as a pharmaceutical, biotechnology, and medical device research and development outsourcing company in China and the United States. It operates in two segments, Laboratory Services and Manufacturing Services. The Laboratory Services segment offers services for small molecules, such as synthetic chemistry, biology, medicinal chemistry, DMPK/ADME, formulation, analytical chemistry, toxicology, clinical development, bioanalytical services, genomics, research reagent production, and clinical services, as well as services for discovery and development of biologics; and laboratory services, including testing services for biologics, medical devices, and combination products. The Manufacturing Services segment produces and manufactures advanced intermediates and active pharmaceutical ingredients for use by pharmaceutical companies in preclinical and clinical trials of small-molecule products and for commercial products, as well as produces biologics. The company sells its products directly to pharmaceutical, biotechnology, and medical device companies. It has strategic collaboration agreement with Foundation Medicine, Inc. Wuxi PharmaTech (Cayman) Inc. was founded in 2000 and is based in Shanghai, China.